Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all shareholders, please read:

It all becomes clear, but still no details as to what experience and qualifications makes this nominee any better positioned than any of the current BoD.

For example, the PDSG situation is now moot, the share price is now moving in the right direction, and information has been provided.

As M&A is currently paused, and, no doubt, the TPL situation is being addressed, just what is it that will be any different to what the current BoD is doing?

.

.

.

Be well

Share
New Message
Please login to post a reply